Equillium, Inc

(NASDAQ:EQ)

Latest On Equillium, Inc (EQ):

Date/Time Type Description Signal Details
2023-05-12 23:04 ESTNewsEquillium: A Negative EV Biotech With Compelling Programs And Cash 'Til At Least 2025; Worth A LookN/A
2023-05-11 19:16 ESTNewsEquillium GAAP EPS of -$0.11 beats by $0.07, revenue of $8.9MN/A
2023-03-23 18:27 ESTNewsEquillium GAAP EPS of $0.08 in-line, revenue of $15.76M beats by $5.36MN/A
2022-12-23 23:44 ESTNewsMetacrine, Equillium call off mergerN/A
2022-12-06 18:46 ESTNewsEquillium grants Ono Pharma an option to purchase rights to itolizumab for about $164MN/A
2022-11-15 18:23 ESTNewsEquillium GAAP EPS of -$0.40 misses by $0.02N/A
2022-10-27 08:00 ESTNewsEquillium: Upgraded To 'Watch Item' StatusN/A
2022-09-27 10:31 ESTNewsEquillium spikes 22% after early Phase 2 data for lupus nephritis candidateN/A
2022-09-07 01:12 ESTNewsEquillium acquires Metacrine to extend cash runway through 2024N/A
2022-08-20 00:01 ESTNewsEquillium, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-16 07:12 ESTNewsEquillium GAAP EPS of -$0.41 in-lineN/A
2022-05-13 12:13 ESTNewsEquillium GAAP EPS of -$1.17N/A
2022-03-24 09:59 ESTNewsEquillium GAAP EPS of -$0.36 misses by $0.06N/A
2022-03-04 22:14 ESTNewsEquillium begins phase 3 trial of itolizumab for graft versus host diseaseN/A
2022-02-16 18:33 ESTNewsEquillium acquires Bioniz Therapeutics in all-stock dealN/A
2022-01-04 12:20 ESTNewsEquillium reports data from Phase 1b EQUIP study; will reassess potential in asthma studyN/A
2021-12-13 19:01 ESTNewsEquillium (EQ) Investor Presentation - SlideshowN/A
2021-11-11 05:15 ESTNewsEquillium EPS misses by $0.01N/A
2021-10-09 02:38 ESTNewsEquillium CEO Bruce Steel - Drugs For Autoimmune, Inflammatory Disorders (Video)N/A
2021-08-11 19:59 ESTNewsEquillium amends early-stage trial of itolizumab for autoimmune diseaseN/A
2021-08-11 00:12 ESTNewsEquillium EPS beats by $0.01N/A
2021-07-21 06:47 ESTNewsEquillium stock falls despite acute graft-versus-host-disease drug shows response in early stage studyN/A
2021-07-21 06:15 ESTNewsEquillium plans to initiate late-stage itolizumab acute graft-versus-host disease trialN/A
2021-03-31 00:57 ESTNewsEquillium rises 9% following positive phase 1 data for lupus candidate itolizumabN/A
2021-03-24 17:43 ESTNewsEquillium EPS beats by $0.02N/A
2021-03-17 22:10 ESTNewsOur First Look At EquilliumN/A
2021-03-16 23:36 ESTNewsEquillium shares rise with response rate seen in acute graft-versus-host disease trialN/A
2021-03-13 03:32 ESTAnalyst RatingThe Analyst Target Price has increased from $15.21 to $15.22.Buy
2021-03-10 11:27 ESTAnalyst RatingThe Analyst Target Price has decreased from $16.25 to $15.21.Neutral
2021-02-12 17:52 ESTNewsEquillium posts interim data from early-stage acute graft-versus-host disease trialN/A
2021-02-04 13:14 ESTNewsEquillium prices $30M registered direct offeringN/A
2020-12-01 11:52 ESTAnalyst RatingThe Analyst Target Price has decreased from $18.75 to $16.25.Neutral
2020-11-26 19:53 ESTFinancialsCompany financials have been released.Neutral
2020-11-25 22:26 ESTNewsEquillium nixes plan to start late-stage trials of COVID-19 treatmentN/A
2020-11-14 11:40 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 11:52 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 20:01 ESTEarnings EstimateAn EPS average of -$0.53 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-11 17:59 ESTNewsEquillium EPS beats by $0.09N/A
2020-11-07 15:44 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 07:31 ESTNewsEquillium rallies 4% on more positive itolizumab dataN/A
2020-10-31 14:48 ESTNewsFDA gives green signal to Equillium's late-stage COVID-19 trialN/A
2020-09-30 17:36 ESTInsider TradeStephen Connelly has directly disposed of 25,000 shares and currently holds 1,018,000 shares.Sell
2020-09-26 12:40 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 04:48 ESTFinancialsCompany financials have been released.Neutral
2020-09-15 13:36 ESTNewsEquillium up 9% on advancement of itolizumab for COVID-19N/A
2020-08-24 04:37 ESTAnalyst RatingThe Analyst Target Price has decreased from $19.25 to $18.75.Neutral
2020-08-14 17:54 ESTNewsEquillium prices equity offering at $7N/A
2020-08-14 16:37 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 08:43 ESTFinancialsCompany financials have been released.Neutral
2020-08-13 16:50 ESTNewsEquillium launches equity offeringN/A

About Equillium, Inc (EQ):

Equillium, Inc., a clinical-stage biotechnology company, develops products for autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Its primary product candidate is itolizumab, a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase 1b/2 clinical trials for the treatment of acute graft-versus-host disease; and Phase 1 clinical trial for the treatment of asthma and lupus nephritis. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was founded in 2017 and is headquartered in La Jolla, California.

EQ Quotes by TradingView

See Advanced Chart

General

  • Name Equillium, Inc
  • Symbol EQ
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 26
  • Fiscal Year EndDecember
  • IPO Date2018-10-11
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://equilliumbio.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 3.02
  • Enterprise Value EBITDA 0.01
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.45
  • Return on Assets -23%
  • Return on Equity -45%
  • Earnings Per Share -$1.41
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 227.38 million
  • EBITDA -19225484
  • PE Ratio -4.52
  • Analyst Target Price $15.22
  • Book Value Per Share $3.16
View More

Share Statistics

  • Shares Outstanding 29.04 million
  • Shares Float 15.31 million
  • % Held by Insiders 4412%
  • % Held by Institutions 34.21%
  • Shares Short 1.06 million
  • Shares Short Prior Month 1.12 million
  • Short Ratio 1.46
  • Short % of Float 7%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 1.72
  • 52 Week High $19.22
  • 52 Week Low $2.2
  • 50 Day Moving Average 7.9
  • 200 Day Moving Average 6.02
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Equillium, Inc (EQ) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Equillium, Inc (EQ) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-10$N/A-$0.31-$0.4429.55%
2020-06-302020-08-12$N/A-$0.37-$0.4415.91%
2020-03-312020-05-13$N/A-$0.45-$0.41-8.88%
2019-12-312020-03-26$N/A-$0.43-$0.40-7.5%
2019-09-302019-11-12$N/A-$0.35-$0.4216.67%
2019-06-302019-08-12$N/A-$0.35-$0.4114.63%
2019-03-312019-05-13$N/A-$0.34-$0.30-13.33%
2018-12-312019-03-27$N/A-$0.33-$0.29-15.1%
2018-09-302018-11-15$N/A-$0.31-$0.11-181.82%

Equillium, Inc (EQ) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Equillium, Inc (EQ) Chart:

Equillium, Inc (EQ) News:

Below you will find a list of latest news for Equillium, Inc (EQ) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Equillium, Inc (EQ) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50.05CALL0 510FALSE00
2024-05-1750CALL0 00FALSE00
2024-05-177.50.2CALL0 190FALSE00
2024-05-172.50PUT0 0270.38TRUE00
2024-05-1750PUT0 0624.26TRUE00
2024-05-177.50PUT0 0665.64TRUE00
2024-06-212.50CALL0 00FALSE00
2024-06-2150CALL0 00FALSE00
2024-06-217.50CALL0 00FALSE00
2024-06-212.50PUT0 0101.98TRUE00
2024-06-2150PUT0 0229.12TRUE00
2024-06-217.50PUT0 0251.97TRUE00
2024-07-192.50.4CALL2 511188.41FALSE00
2024-07-1950.15CALL2 676191.37FALSE00
2024-07-197.50.25CALL0 00FALSE00
2024-07-192.50PUT0 0112.84TRUE00
2024-07-1950PUT0 0261.19TRUE00
2024-07-197.50PUT0 0175.5TRUE00
2024-10-182.50.99CALL0 26263.24FALSE00
2024-10-1850.1CALL0 130167.55FALSE00
2024-10-187.50CALL0 00FALSE00
2024-10-182.50PUT0 0115.17TRUE00
2024-10-1850PUT0 0125.36TRUE00
2024-10-187.50PUT0 0158.73TRUE00

Latest EQ Trades:

Date Shares Price
Jun 13, 2022 2:27 PM EST100$2.11
Jun 13, 2022 7:20 PM EST100$2.02
Jun 13, 2022 7:59 PM EST241$2.09
Jun 13, 2022 7:59 PM EST100$2.09

Equillium, Inc (EQ) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120036285/0001209191-20-036285-index.htm
2018-08-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1746466/000000000018026763/0000000000-18-026763-index.htm
2018-09-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1746466/000000000018028897/0000000000-18-028897-index.htm
2018-09-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1746466/000000000018030430/0000000000-18-030430-index.htm
2018-10-01UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1746466/000000000018030877/0000000000-18-030877-index.htm
2019-11-20UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1746466/000000000019015686/0000000000-19-015686-index.htm
2020-04-02UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1746466/000000000020002854/0000000000-20-002854-index.htm
2018-08-03DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1746466/000095012318007408/0000950123-18-007408-index.htm
2018-08-30DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1746466/000095012318009228/0000950123-18-009228-index.htm
2018-08-30DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1746466/000095012318009230/0000950123-18-009230-index.htm
2019-02-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1746466/000104018819000078/0001040188-19-000078-index.htm
2019-08-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1746466/000104018819000095/0001040188-19-000095-index.htm
2020-01-29SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1746466/000104018820000012/0001040188-20-000012-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1746466/000110465920021665/0001104659-20-021665-index.htm
2018-10-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1746466/000114420418054737/0001144204-18-054737-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1746466/000114420419008382/0001144204-19-008382-index.htm
2018-09-17S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1746466/000119312518275420/0001193125-18-275420-index.htm
2018-09-17CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1746466/000119312518275425/0001193125-18-275425-index.htm
2018-09-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1746466/000119312518280413/0001193125-18-280413-index.htm
2018-09-28S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1746466/000119312518286265/0001193125-18-286265-index.htm
2018-09-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1746466/000119312518286279/0001193125-18-286279-index.htm
2018-10-02S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1746466/000119312518290169/0001193125-18-290169-index.htm
2018-10-02CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1746466/000119312518290182/0001193125-18-290182-index.htm
2018-10-058-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1746466/000119312518294689/0001193125-18-294689-index.htm
2018-10-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1746466/000119312518296028/0001193125-18-296028-index.htm
2018-10-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1746466/000119312518296034/0001193125-18-296034-index.htm
2018-10-12424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1746466/000119312518298453/0001193125-18-298453-index.htm
2018-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000119312518300246/0001193125-18-300246-index.htm
2018-10-16S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1746466/000119312518300276/0001193125-18-300276-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000119312518324657/0001193125-18-324657-index.htm
2018-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000119312518327998/0001193125-18-327998-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000119312518354533/0001193125-18-354533-index.htm
2019-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000119312519045346/0001193125-19-045346-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000119312519051928/0001193125-19-051928-index.htm
2019-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000119312519130143/0001193125-19-130143-index.htm
2019-11-13S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1746466/000119312519291182/0001193125-19-291182-index.htm
2019-11-21CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1746466/000119312519297572/0001193125-19-297572-index.htm
2019-11-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000119312519302509/0001193125-19-302509-index.htm
2019-12-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000119312519312050/0001193125-19-312050-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000119312520156556/0001193125-20-156556-index.htm
2020-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000119312520191424/0001193125-20-191424-index.htm
2020-07-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1746466/000119312520192218/0001193125-20-192218-index.htm
2020-07-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000119312520192229/0001193125-20-192229-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000119312520215058/0001193125-20-215058-index.htm
2020-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000119312520217090/0001193125-20-217090-index.htm
2020-08-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1746466/000119312520219125/0001193125-20-219125-index.htm
2020-08-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1746466/000119312520220489/0001193125-20-220489-index.htm
2020-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000119312520220538/0001193125-20-220538-index.htm
2020-09-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000119312520256711/0001193125-20-256711-index.htm
2020-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000119312520281174/0001193125-20-281174-index.htm
2018-10-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919118054831/0001209191-18-054831-index.htm
2018-10-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919118054834/0001209191-18-054834-index.htm
2018-10-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919118054836/0001209191-18-054836-index.htm
2018-10-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919118054838/0001209191-18-054838-index.htm
2018-10-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919118054842/0001209191-18-054842-index.htm
2018-10-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919118054845/0001209191-18-054845-index.htm
2018-10-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919118054847/0001209191-18-054847-index.htm
2018-10-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919118054853/0001209191-18-054853-index.htm
2018-10-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919118054855/0001209191-18-054855-index.htm
2018-10-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919118054864/0001209191-18-054864-index.htm
2018-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919118055166/0001209191-18-055166-index.htm
2018-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919118055168/0001209191-18-055168-index.htm
2018-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919118055170/0001209191-18-055170-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919119010761/0001209191-19-010761-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919119010762/0001209191-19-010762-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919119010766/0001209191-19-010766-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919119010767/0001209191-19-010767-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919119010768/0001209191-19-010768-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919119036798/0001209191-19-036798-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919119036801/0001209191-19-036801-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919119036804/0001209191-19-036804-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919119036807/0001209191-19-036807-index.htm
2019-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919119044617/0001209191-19-044617-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919119048262/0001209191-19-048262-index.htm
2019-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919119060268/0001209191-19-060268-index.htm
2019-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919119060269/0001209191-19-060269-index.htm
2019-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919119060270/0001209191-19-060270-index.htm
2019-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919119060272/0001209191-19-060272-index.htm
2019-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919119060275/0001209191-19-060275-index.htm
2020-01-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120000409/0001209191-20-000409-index.htm
2020-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120004544/0001209191-20-004544-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120010740/0001209191-20-010740-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120025655/0001209191-20-025655-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120025656/0001209191-20-025656-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120025659/0001209191-20-025659-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120031273/0001209191-20-031273-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120031274/0001209191-20-031274-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120031275/0001209191-20-031275-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120031276/0001209191-20-031276-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120031277/0001209191-20-031277-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120031278/0001209191-20-031278-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120032936/0001209191-20-032936-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120032937/0001209191-20-032937-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120032938/0001209191-20-032938-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120032939/0001209191-20-032939-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120036284/0001209191-20-036284-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120036285/0001209191-20-036285-index.htm
2020-07-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120042499/0001209191-20-042499-index.htm
2020-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1746466/000120919120052467/0001209191-20-052467-index.htm
2018-10-12CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1746466/000135445718000407/0001354457-18-000407-index.htm
2018-11-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1746466/000156459018029687/0001564590-18-029687-index.htm
2019-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000156459019009579/0001564590-19-009579-index.htm
2019-03-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1746466/000156459019009580/0001564590-19-009580-index.htm
2019-03-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1746466/000156459019009583/0001564590-19-009583-index.htm
2019-04-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1746466/000156459019013052/0001564590-19-013052-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000156459019018833/0001564590-19-018833-index.htm
2019-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1746466/000156459019018839/0001564590-19-018839-index.htm
2019-05-24S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1746466/000156459019020466/0001564590-19-020466-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000156459019022336/0001564590-19-022336-index.htm
2019-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000156459019031480/0001564590-19-031480-index.htm
2019-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1746466/000156459019031483/0001564590-19-031483-index.htm
2019-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000156459019036089/0001564590-19-036089-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000156459019042913/0001564590-19-042913-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1746466/000156459019042933/0001564590-19-042933-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000156459020013200/0001564590-20-013200-index.htm
2020-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1746466/000156459020013207/0001564590-20-013207-index.htm
2020-03-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1746466/000156459020013212/0001564590-20-013212-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000156459020014185/0001564590-20-014185-index.htm
2020-03-30S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1746466/000156459020014306/0001564590-20-014306-index.htm
2020-04-03DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1746466/000156459020015262/0001564590-20-015262-index.htm
2020-04-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1746466/000156459020015267/0001564590-20-015267-index.htm
2020-04-07424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1746466/000156459020015736/0001564590-20-015736-index.htm
2020-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000156459020018536/0001564590-20-018536-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000156459020025054/0001564590-20-025054-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1746466/000156459020025063/0001564590-20-025063-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1746466/000156459020026454/0001564590-20-026454-index.htm
2020-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1746466/000156459020039503/0001564590-20-039503-index.htm
2018-10-11EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1746466/999999999518002599/9999999995-18-002599-index.htm
2019-11-25EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1746466/999999999519002656/9999999995-19-002656-index.htm
2020-04-07EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1746466/999999999520000701/9999999995-20-000701-index.htm
2018-10-12CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1746466/999999999718008544/9999999997-18-008544-index.htm

Equillium, Inc (EQ) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Equillium, Inc (EQ). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 4412%
Institutional Ownership: 3421%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-09-28Stephen ConnellyChief Scientific OfficerSell25,000.005.62140,395.001,018,000.00https://www.sec.gov/Archives/edgar/data/1746466/000120919120052467/0001209191-20-052467-index.htm
2020-07-13Stephen ConnellyChief Scientific OfficerSell250,000.008.132,033,475.001,043,000.00https://www.sec.gov/Archives/edgar/data/1746466/000120919120042499/0001209191-20-042499-index.htm
2020-02-18Jason A KeyesChief Financial OfficerSell5,000.005.0325,137.50130,520.00https://www.sec.gov/Archives/edgar/data/1746466/000120919120010740/0001209191-20-010740-index.htm
2020-01-21Jason A KeyesChief Financial OfficerSell5,000.004.4122,043.00135,520.00https://www.sec.gov/Archives/edgar/data/1746466/000120919120004544/0001209191-20-004544-index.htm
2019-09-03Jason A KeyesChief Financial OfficerSell5,000.003.6017,980.50138,720.00https://www.sec.gov/Archives/edgar/data/1746466/000120919119048262/0001209191-19-048262-index.htm
2019-08-01Jason A KeyesChief Financial OfficerSell5,000.003.9919,941.00143,720.00https://www.sec.gov/Archives/edgar/data/1746466/000120919119044617/0001209191-19-044617-index.htm
2018-10-16SA Biocon10% Share HolderBuy228,060.002,316,134.00https://www.sec.gov/Archives/edgar/data/1746466/000120919118055166/0001209191-18-055166-index.htm